Click for best price
Wilson's Disease Drugs Market Size, Share 2022
Wilson's Disease Drugs are used to reduce excessive copper in serum, indirectly reducing the accumulation of copper in various tissues of the body.
This report contains market size and forecasts of Wilson's Disease Drugs in Global, including the following market information:
Global Wilson's Disease Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Wilson's Disease Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hepatic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Wilson's Disease Drugs include Kadmon Holdings, Inc., Merck & Co., Teva Pharmaceutical Industries Limited, Tsumura & Co., Valeant Pharmaceuticals International, Inc., VHB Life Sciences, Inc. and Wilson Therapeutics AB (Alexion), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Wilson's Disease Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Wilson's Disease Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Wilson's Disease Drugs Market Segment Percentages, by Type, 2021 (%)
Hepatic
Neuropsychiatric
Ophthalmic
Others
Global Wilson's Disease Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Wilson's Disease Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Wilson's Disease Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Wilson's Disease Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Wilson's Disease Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Wilson's Disease Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Kadmon Holdings, Inc.
Merck & Co.
Teva Pharmaceutical Industries Limited
Tsumura & Co.
Valeant Pharmaceuticals International, Inc.
VHB Life Sciences, Inc.
Wilson Therapeutics AB (Alexion)
| Report Attributes |
Report Details |
| Report Title |
Wilson's Disease Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Wilson's Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Wilson's Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Wilson's Disease Drugs Overall Market Size
2.1 Global Wilson's Disease Drugs Market Size: 2021 VS 2028
2.2 Global Wilson's Disease Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Wilson's Disease Drugs Players in Global Market
3.2 Top Global Wilson's Disease Drugs Companies Ranked by Revenue
3.3 Global Wilson's Disease Drugs Revenue by Companies
3.4 Top 3 and Top 5 Wilson's Disease Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Wilson's Disease Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Wilson's Disease Drugs Players in Global Market
3.6.1 List of Global Tier 1 Wilson's Disease Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Wilson's Disease Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Wilson's Disease Drugs Market Size Markets, 2021 & 2028
4.1.2 Hepatic
4.1.3 Neuropsychiatric
4.1.4 Ophthalmic
4.1.5 Others
4.2 By Type - Global Wilson's Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Wilson's Disease Drugs Revenue, 2017-2022
4.2.2 By Type - Global Wilson's Disease Drugs Revenue, 2023-2028
4.2.3 By Type - Global Wilson's Disease Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Wilson's Disease Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Wilson's Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Wilson's Disease Drugs Revenue, 2017-2022
5.2.2 By Application - Global Wilson's Disease Drugs Revenue, 2023-2028
5.2.3 By Application - Global Wilson's Disease Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Wilson's Disease Drugs Market Size, 2021 & 2028
6.2 By Region - Global Wilson's Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Wilson's Disease Drugs Revenue, 2017-2022
6.2.2 By Region - Global Wilson's Disease Drugs Revenue, 2023-2028
6.2.3 By Region - Global Wilson's Disease Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Wilson's Disease Drugs Revenue, 2017-2028
6.3.2 US Wilson's Disease Drugs Market Size, 2017-2028
6.3.3 Canada Wilson's Disease Drugs Market Size, 2017-2028
6.3.4 Mexico Wilson's Disease Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Wilson's Disease Drugs Revenue, 2017-2028
6.4.2 Germany Wilson's Disease Drugs Market Size, 2017-2028
6.4.3 France Wilson's Disease Drugs Market Size, 2017-2028
6.4.4 U.K. Wilson's Disease Drugs Market Size, 2017-2028
6.4.5 Italy Wilson's Disease Drugs Market Size, 2017-2028
6.4.6 Russia Wilson's Disease Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Wilson's Disease Drugs Market Size, 2017-2028
6.4.8 Benelux Wilson's Disease Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Wilson's Disease Drugs Revenue, 2017-2028
6.5.2 China Wilson's Disease Drugs Market Size, 2017-2028
6.5.3 Japan Wilson's Disease Drugs Market Size, 2017-2028
6.5.4 South Korea Wilson's Disease Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Wilson's Disease Drugs Market Size, 2017-2028
6.5.6 India Wilson's Disease Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Wilson's Disease Drugs Revenue, 2017-2028
6.6.2 Brazil Wilson's Disease Drugs Market Size, 2017-2028
6.6.3 Argentina Wilson's Disease Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Wilson's Disease Drugs Revenue, 2017-2028
6.7.2 Turkey Wilson's Disease Drugs Market Size, 2017-2028
6.7.3 Israel Wilson's Disease Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Wilson's Disease Drugs Market Size, 2017-2028
6.7.5 UAE Wilson's Disease Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Kadmon Holdings, Inc.
7.1.1 Kadmon Holdings, Inc. Corporate Summary
7.1.2 Kadmon Holdings, Inc. Business Overview
7.1.3 Kadmon Holdings, Inc. Wilson's Disease Drugs Major Product Offerings
7.1.4 Kadmon Holdings, Inc. Wilson's Disease Drugs Revenue in Global Market (2017-2022)
7.1.5 Kadmon Holdings, Inc. Key News
7.2 Merck & Co.
7.2.1 Merck & Co. Corporate Summary
7.2.2 Merck & Co. Business Overview
7.2.3 Merck & Co. Wilson's Disease Drugs Major Product Offerings
7.2.4 Merck & Co. Wilson's Disease Drugs Revenue in Global Market (2017-2022)
7.2.5 Merck & Co. Key News
7.3 Teva Pharmaceutical Industries Limited
7.3.1 Teva Pharmaceutical Industries Limited Corporate Summary
7.3.2 Teva Pharmaceutical Industries Limited Business Overview
7.3.3 Teva Pharmaceutical Industries Limited Wilson's Disease Drugs Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Limited Wilson's Disease Drugs Revenue in Global Market (2017-2022)
7.3.5 Teva Pharmaceutical Industries Limited Key News
7.4 Tsumura & Co.
7.4.1 Tsumura & Co. Corporate Summary
7.4.2 Tsumura & Co. Business Overview
7.4.3 Tsumura & Co. Wilson's Disease Drugs Major Product Offerings
7.4.4 Tsumura & Co. Wilson's Disease Drugs Revenue in Global Market (2017-2022)
7.4.5 Tsumura & Co. Key News
7.5 Valeant Pharmaceuticals International, Inc.
7.5.1 Valeant Pharmaceuticals International, Inc. Corporate Summary
7.5.2 Valeant Pharmaceuticals International, Inc. Business Overview
7.5.3 Valeant Pharmaceuticals International, Inc. Wilson's Disease Drugs Major Product Offerings
7.5.4 Valeant Pharmaceuticals International, Inc. Wilson's Disease Drugs Revenue in Global Market (2017-2022)
7.5.5 Valeant Pharmaceuticals International, Inc. Key News
7.6 VHB Life Sciences, Inc.
7.6.1 VHB Life Sciences, Inc. Corporate Summary
7.6.2 VHB Life Sciences, Inc. Business Overview
7.6.3 VHB Life Sciences, Inc. Wilson's Disease Drugs Major Product Offerings
7.6.4 VHB Life Sciences, Inc. Wilson's Disease Drugs Revenue in Global Market (2017-2022)
7.6.5 VHB Life Sciences, Inc. Key News
7.7 Wilson Therapeutics AB (Alexion)
7.7.1 Wilson Therapeutics AB (Alexion) Corporate Summary
7.7.2 Wilson Therapeutics AB (Alexion) Business Overview
7.7.3 Wilson Therapeutics AB (Alexion) Wilson's Disease Drugs Major Product Offerings
7.7.4 Wilson Therapeutics AB (Alexion) Wilson's Disease Drugs Revenue in Global Market (2017-2022)
7.7.5 Wilson Therapeutics AB (Alexion) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Wilson's Disease Drugs Market Opportunities & Trends in Global Market
Table 2. Wilson's Disease Drugs Market Drivers in Global Market
Table 3. Wilson's Disease Drugs Market Restraints in Global Market
Table 4. Key Players of Wilson's Disease Drugs in Global Market
Table 5. Top Wilson's Disease Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Wilson's Disease Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Wilson's Disease Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Wilson's Disease Drugs Product Type
Table 9. List of Global Tier 1 Wilson's Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Wilson's Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Wilson's Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Wilson's Disease Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Wilson's Disease Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Wilson's Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Wilson's Disease Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Wilson's Disease Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Wilson's Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Wilson's Disease Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Wilson's Disease Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Wilson's Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Wilson's Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Wilson's Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Wilson's Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Wilson's Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Kadmon Holdings, Inc. Corporate Summary
Table 31. Kadmon Holdings, Inc. Wilson's Disease Drugs Product Offerings
Table 32. Kadmon Holdings, Inc. Wilson's Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Merck & Co. Corporate Summary
Table 34. Merck & Co. Wilson's Disease Drugs Product Offerings
Table 35. Merck & Co. Wilson's Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Teva Pharmaceutical Industries Limited Corporate Summary
Table 37. Teva Pharmaceutical Industries Limited Wilson's Disease Drugs Product Offerings
Table 38. Teva Pharmaceutical Industries Limited Wilson's Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Tsumura & Co. Corporate Summary
Table 40. Tsumura & Co. Wilson's Disease Drugs Product Offerings
Table 41. Tsumura & Co. Wilson's Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Valeant Pharmaceuticals International, Inc. Corporate Summary
Table 43. Valeant Pharmaceuticals International, Inc. Wilson's Disease Drugs Product Offerings
Table 44. Valeant Pharmaceuticals International, Inc. Wilson's Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 45. VHB Life Sciences, Inc. Corporate Summary
Table 46. VHB Life Sciences, Inc. Wilson's Disease Drugs Product Offerings
Table 47. VHB Life Sciences, Inc. Wilson's Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Wilson Therapeutics AB (Alexion) Corporate Summary
Table 49. Wilson Therapeutics AB (Alexion) Wilson's Disease Drugs Product Offerings
Table 50. Wilson Therapeutics AB (Alexion) Wilson's Disease Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Wilson's Disease Drugs Segment by Type in 2021
Figure 2. Wilson's Disease Drugs Segment by Application in 2021
Figure 3. Global Wilson's Disease Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Wilson's Disease Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Wilson's Disease Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Wilson's Disease Drugs Revenue in 2021
Figure 8. By Type - Global Wilson's Disease Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Wilson's Disease Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Wilson's Disease Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Wilson's Disease Drugs Revenue Market Share, 2017-2028
Figure 12. US Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Wilson's Disease Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Wilson's Disease Drugs Revenue Market Share, 2017-2028
Figure 24. China Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Wilson's Disease Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Wilson's Disease Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Wilson's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Kadmon Holdings, Inc. Wilson's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck & Co. Wilson's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Teva Pharmaceutical Industries Limited Wilson's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Tsumura & Co. Wilson's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Valeant Pharmaceuticals International, Inc. Wilson's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. VHB Life Sciences, Inc. Wilson's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Wilson Therapeutics AB (Alexion) Wilson's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
